Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of September 2024. The report specifically details a transaction in the company's own shares executed on September 16, 2024, under a share buyback programme announced on August 1, 2024.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. It focuses exclusively on share repurchase activity:
- Shares Purchased: 656,800 ordinary shares
- Highest Price Paid: 397.30 pence per share
- Lowest Price Paid: 393.70 pence per share
- Volume Weighted Average Price: 395.8035 pence per share
- Post-Transaction Share Capital: 9,118,471,572 ordinary shares
Material Changes
The primary material change reported is the reduction of the company's registered share capital following the cancellation of the 656,800 purchased shares. No other material changes to financial position or operations are disclosed in this specific filing.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future performance, or discussion of risks and contingencies. It serves as a regulatory disclosure of a completed transaction in compliance with the Market Abuse Regulation (Article 5s(1)(b)).
Key Facts for Investor Verification
- Verify the total number of shares repurchased to date under the August 2024 Buyback Programme.
- Confirm the remaining authorized buyback amount and the programme's end date.
- Review the full trade breakdown available via the London Stock Exchange link provided in the filing for granular transaction data.
- Check subsequent filings for updated share capital figures and any impact on earnings per share.